Article citationsMore>>

G. Romano, E. Corrado, I. Muratori, G. Novo, G. Andolina, V. Cospite, et al., “Carotid and Peripheral Atherosclerosis in Patients Who Underwent Primary Percutaneous Coronary Intervention and Outcome Associated with Multifocal Atherosclerosis,” International Journal of Angiology, Vol. 25, No. 4, 2006, pp. 389-394.

has been cited by the following article:

• TITLE: Importance of Ankle/Brachial Pressure Index in Saudi Patients with Coronary Artery Disease

  AUTHORS: Abdullah M. Alshehri, Mohamed Elsharawy

  KEYWORDS: Coronary Artery Disease; Ankle Brachial Pressure Index; Atherosclerosis

  JOURNAL NAME: World Journal of Cardiovascular Surgery, Vol.3 No.6, October 7, 2013

  ABSTRACT: Background: The ankle/brachial pressure index (ABPI) has been shown to be a good marker of systemic atherosclerosis and a powerful predictor of cardiovascular morbidity and mortality. The objective of this study was to determine the importance of measuring ABPI in Saudi patients with coronary artery disease (CAD). METHODS: This is a hospital based cross-sectional study which was conducted on all Saudi patients who underwent coronary angiography without symptoms of peripheral arterial disease at King Fahd Hospital of the University, Al-Khobar Saudi Arabia. All patients underwent measurement of their ABPI. The study was carried out between December 2010 and November 2011. RESULTS: During the study period, two hundred and five patients were included. Fifty-nine (28.8%) patients were Group II (ABPI ≤ 0.90) and the rest was Group I (ABPI > 0.90). Significant correlation was also found between low ABPI and the extent of CAD (mean number of arteries involved in Group I was 1.78 ± 0.83 compared to 2.10 ± 0.736 in Group II p = 0.011). Nevertheless, the correlation between low ABPI, and the severity of presentation of CAD were also significant (Incidence of myocardial infarction with congestive heart failure was 0.5% in Group I compared to 12% in Group II p CONCLUSION: The ABPI is an important prognostic indicator for Saudi patients with CAD.